NCT05498792 2026-05-22Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in MelanomaFox Chase Cancer CenterPhase EARLY_PHASE1 Recruiting12 enrolled
NCT03727789 2024-03-27CBL0137 in Treating Patients With Advanced Extremity Melanoma or SarcomaRoswell Park Cancer InstitutePhase 1 Terminated7 enrolled